September 7, 2018—BD (Becton, Dickinson and Company) announced that is has received FDA approval for the 220-mm length of its Lutonix 035 drug-coated balloon (DCB) for the treatment of long superficial femoral artery (SFA) lesions in patients with peripheral artery disease (PAD).
“The new longer lengths of the Lutonix 035 DCB represent a tremendous opportunity for physicians to enhance their PAD treatment in long lesions with a proven technology that will now require fewer DCBs and fewer inflations, reducing DCB healthcare expenditures overall,” commented vascular surgeon Chad Laurich, MD, in the company's announcement.
BD noted that in the Lutonix Global SFA Real-World Registry, 22% of the femoropopliteal lesions were longer than 150 mm. In some of these patients, multiple DCBs were used to cover the length of the long lesion. With the approval of the 220-mm device, more disease can be treated with a single Lutonix 035 DCB.
advertisement
Featured Video
Hear the full IMPERIAL Trial presentation from the Principal Investigator, William Gray, MD.
Sponsored by Boston Scientific
Related Articles
Economics and Cost Effectiveness of Managing Complex Lesions
Analyzing data on the cost of drug-coated balloons, drug-eluting stents, percutaneous transluminal angioplasty, and bare-metal stents for the treatment of peripheral artery disease.
By Mahmood K. Razavi, MD, FSIR, FSVM
Top 5 Articles From August 2018
Emerging Tools for Lytic-Free, Single-Session Treatment of Venous Thromboembolic Disease
The ClotTriever Outcomes (CLOUT) registry principal investigators share their current DVT practices and thoughts on the new study, and DVT and PE case reports are presented using the Inari Medical ClotTriever and FlowTriever Systems.
With Robert E. Beasley, MD, FSIR, FSCAI; William Marston, MD; Suman Annambhotla, MD; and Wissam A. Jaber, MD
Left Superficial Femoral Artery Occlusion in a Patient With an Aortobifemoral Graft
By Moderator: Ehrin J. Armstrong, MD
Panel: Steve Henao, MD, FACC, FACS; Sahil A. Parikh, MD, FACC, FSCAI; and Saher Sabri, MD, FSIR
Residual Dissection and False Lumen Aneurysm After TEVAR
By Moderator: Mark Farber, MD
Panel: Yazan Duwayri, MD; Matthew J. Eagleton, MD; William D. Jordan Jr, MD; Tilo Kölbel, MD, PhD; and Eric L.G. Verhoeven, MD, PhD
Incidental Splenic Artery Aneurysm on CT Imaging
By Moderator: Paul J. Rochon, MD, FSIR
Panel: Vishal Kumar, MD; Kumar Madassery, MD; and Waleska M. Pabon-Ramos, MD, MPH, FSIR
Carotid Occlusion With Middle Cerebral Artery Thrombus
By Moderators: Adnan H. Siddiqui, MD, PhD; and Kunal Vakharia, MD;
Panel: Ansaar T. Rai, MD, MBA; and Aquilla S. Turk, DO
Top 5 from CIToday's Current Issue
CT Assessment Before TMVR
By Moderator: Dee Dee Wang, MD, FACC, FASE, FSCCT
Panel: Mayra Guerrero, MD; and Marco Barbanti, MD
Challenging Cases: What Would You Do?
By Ted E. Feldman, MD, MSCAI, FACC, FESC; and Shakeel A. Qureshi, MD, FRCP, FRCPCH
Complicated Radial Access During Primary PCI
By Moderator: Pieter C. Smits, MD, PhD, FESC
Panel: Mohamed Abdel-Wahab, MD, FESC; Peter W. Danse, MD; and Valeria Paradies, MD
Planning for Transcatheter Aortic Valve Replacement
By Moderator: Mauricio G. Cohen, MD, FACC, FSCAI
Panel: Santiago Garcia, MD, FACC, FSCAI; William O’Neill, MD; and Molly Szerlip, MD, FACC, FSCAI
Peripheral Vascular Programs Could Improve Population Health and Grow Volumes
An overview of the steps involved in developing a PAD program to address this underserved patient population.
